PrEP

Senate testimony on FY25 appropriations for HIV and hepatitis programs

Our nation can eliminate both HIV and viral hepatitis, but without investing additional resources to accelerate our efforts, we will continue to fall short of these ambitious goals. Increased investment–and certainly not cuts–in surveillance, education, prevention, and care and treatment will lead to further progress in reducing HIV and viral hepatitis, which include taking a syndemic approach to achieve maximum impact.

read more

House testimony on FY25 appropriations for HIV and hepatitis programs

Our nation can eliminate both HIV and viral hepatitis, but without an infusion of new resources to accelerate our efforts, we will continue to fall short of these ambitious goals. While we realize strict spending caps are in place, increased investment – and certainly not cuts – in surveillance, education, prevention, and care and treatment will lead to further progress in reducing HIV and viral hepatitis, which include taking a syndemic approach to achieve maximum impact. The programs and funding increases detailed below are pivotal to our nation’s ability to end both these potentially deadly infectious diseases.

read more

Oppose domestic HIV programs cuts of $767 million & proposed amendments

The HIV+Hepatitis Policy Institute urges all members of the House of Representatives to oppose the FY24 Labor HHS Appropriations Bill (HR 5894) due to the $767 million in cuts to HIV domestic prevention and treatment programs, massive cuts to other related programs, and the many damaging social policy riders that are directed to the communities most impacted by HIV.

read more

Support for MA state bills to address barriers to HIV prevention medication

On behalf of the HIV+Hepatitis Policy Institute, we respectfully submit this testimony in support of H.1085/S.619: An Act to address barriers to HIV prevention medication. We need to ensure that everyone is able to benefit from the results of the latest scientific innovations in HIV prevention.  We urge the passage of this important bill to ensure that all Bay Staters using commercial insurance can access PrEP without a financial barrier or delay. 

read more

Impact of proposed elimination of HRSA HIV PrEP funding for community health centers

As part of $767 million of domestic HIV prevention and treatment funding cuts included in the House Labor, HHS Appropriations bill is the total elimination of a program initiated by the Trump administration that is a critical component of the Ending the HIV Epidemic program. The Primary Care HIV Prevention (PCHP) program provides funding to HRSA’s community health centers in the communities most impacted by HIV to conduct activities to support and provide PrEP, which are highly effective medications that prevent HIV.

read more

Pin It on Pinterest